These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11264190

  • 1. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.
    Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL, Jordan CT.
    Blood; 2001 Apr 01; 97(7):2177-9. PubMed ID: 11264190
    [Abstract] [Full Text] [Related]

  • 2. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
    Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE.
    Leukemia; 1999 May 01; 13(5):687-98. PubMed ID: 10374871
    [Abstract] [Full Text] [Related]

  • 3. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
    Feuring-Buske M, Hogge DE.
    Blood; 2001 Jun 15; 97(12):3882-9. PubMed ID: 11389030
    [Abstract] [Full Text] [Related]

  • 4. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R, Mallet F, Chambost H, Sainty D, Arnoulet C, Gastaut JA, Olive D.
    Leukemia; 1999 Oct 15; 13(10):1513-8. PubMed ID: 10516751
    [Abstract] [Full Text] [Related]

  • 5. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
    Xiao M, Oppenlander BK, Plunkett JM, Dooley DC.
    Exp Hematol; 1999 May 15; 27(5):916-27. PubMed ID: 10340408
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3.
    Holyoake TL, Jiang X, Jorgensen HG, Graham S, Alcorn MJ, Laird C, Eaves AC, Eaves CJ.
    Blood; 2001 Feb 01; 97(3):720-8. PubMed ID: 11157490
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.
    Keyhani A, Huh YO, Jendiroba D, Pagliaro L, Cortez J, Pierce S, Pearlman M, Estey E, Kantarjian H, Freireich EJ.
    Leuk Res; 2000 Feb 01; 24(2):153-9. PubMed ID: 10654451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
    von Laer D, Corovic A, Vogt B, Fehse B, Roscher S, Rimek A, Baum C, Ostertag W.
    Leukemia; 2000 May 01; 14(5):947-8. PubMed ID: 10803533
    [No Abstract] [Full Text] [Related]

  • 20. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
    Erickson PF, Dessev G, Lasher RS, Philips G, Robinson M, Drabkin HA.
    Blood; 1996 Sep 01; 88(5):1813-23. PubMed ID: 8781439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.